Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 244

Long-living wild mouse may hold secret to healthy aging

When it comes to health, some of our animal neighbors have extraordinary advantages. Ostriches, for example, are highly resistant to viruses, while sharks rarely develop cancer. And species like naked mole rats and bowhead whales live for astonishingly long periods of time, decades and centuries, respectively.

Researchers are now starting to understand why another species—the golden spiny mouse—seems to be unhindered by the negative health effects that typically accompany aging.

Reporting in Science Advances, researchers at Yale School of Medicine (YSM) have begun to uncover how this wild mouse, native to rocky deserts in the Middle East, resists physical, cognitive, and immunological decline while living six to seven times longer than other wild mice.

Varicella zoster virus and the central nervous system

Varicella zoster virus (VZV) infection causes varicella and herpes zoster and, rarely, severe central nervous system (CNS) complications, including encephalitis. Ogunjimi et al. review the evidence linking herpes zoster with stroke and dementia, summarize innate and adaptive immune responses to VZV-related CNS disease, and debate the consequences of vaccination.

Gut bacteria can sense their environment and it’s key to your health

Your gut bacteria are chemical detectives—sniffing out nutrients and even feeding each other to keep your microbiome thriving. Your gut is home to trillions of bacteria that constantly “sense” their surroundings to survive and thrive. New research shows that beneficial gut microbes, especially common Clostridia bacteria, can detect a surprisingly wide range of chemical signals produced during digestion, including byproducts of fats, proteins, sugars, and even DNA. These microbes use specialized sensors to move toward valuable nutrients, with lactate and formate standing out as especially important fuel sources.

The gut microbiome, also called the gut flora, plays a vital role in human health. This enormous and constantly changing community of microorganisms is shaped by countless chemical exchanges, both among the microbes themselves and between microbes and the human body. For these interactions to work, gut bacteria must be able to detect nutrients and chemical signals around them. Despite their importance, scientists still know relatively little about the full range of signals that bacterial receptors can recognize.

A key question remains. Which chemical signals matter most to beneficial gut bacteria?

Group B Streptococcal Disease

Group B streptococcus commonly colonizes the human gastrointestinal and genitourinary tracts and is the single most common bacterial cause of invasive infection among newborns in the United States. Intrapartum antibiotic prophylaxis is currently used to reduce the risk of group B streptococcal disease among pregnant persons and newborns. No strategies are currently available to prevent disease in later infancy or among nonpregnant adults. Vaccines against group B streptococcal disease that consist of capsular polysaccharides linked to protein antigens are in development and may provide a means of prevention for all at-risk populations.

Semaglutide May Reverse Damage Caused by Osteoarthritis, Study Suggests

Medical researchers have discovered that semaglutide may reverse the debilitating tissue damage caused by osteoarthritis, the world’s most common form of arthritis.

The drug behind Ozempic and Wegovy is best known for treating type 2 diabetes and helping people lose weight. But the new study found semaglutide appears to protect joints in mice through a mechanism that’s not about easing pressure through weight loss.

Instead, the drug reprograms the metabolism of cells that synthesize and maintain healthy cartilage, allowing them to generate more energy.

Size-shifting nanoparticles successfully deliver mRNA medicine to the pancreas

In recent years, mRNA in lipid nanoparticles (mRNA–LNPs) has emerged as a promising strategy for treating numerous conditions, including COVID-19, various cancers and chronic genetic disorders. To date, this technology has not been successfully used for pancreatic diseases, but that could be about to change. In a paper published in Nature, scientists from China report the development of a new lipid nanoparticle drug-delivery system specifically designed for the pancreas.

Lipid nanoparticles are a special class of fat-based carriers that encapsulate and deliver nucleic acids such as messenger RNA into cells. Among the reasons they have not worked for the pancreas until now is that most LNPs naturally accumulate in the liver and spleen. That means the therapeutic molecules they carry can’t accumulate to high enough levels to be beneficial.

However, the research team realized that while the liver and spleen are wrapped in a dense, protective outer layer called a capsule, the pancreas is only covered by a thin layer of connective tissue. They wondered if these organ capsules act as a biological filter. If so, they could perhaps design nanoparticles large enough to be physically blocked by the walls of the spleen and liver, leaving the pancreas as the only place to go. They named this discovery the capsule-filter-mediated pancreatic-targeted (CAMP) mechanism.

Cellular Reprogramming: The Expert Roundup

Cellular reprogramming is one of the technologies most associated with longevity. The field was created in 2006, when Shinya Yamanaka showed that a cocktail of four transcription factors, commonly known as OSKM, can cause de-differentiation and massive rejuvenation of a cell, creating an iPSC (induced pluripotent stem cell). About a decade later, partial reprogramming was demonstrated in vivo, where a more subtle application of the factors led to rejuvenation without compromising the cell’s identity.

Today, this field is maturing quickly, with its first clinical trials just around the corner. Academic teams and companies are working on dozens of directions and applications. We asked four experts, all involved in reprogramming-related biotech companies, to talk about their companies’ approaches and the opportunities and bottlenecks that the field faces and to offer predictions for the near and not-so-near future.

What I find most compelling about cellular reprogramming is that it revealed aging to be, at least in part, an actively maintained biological state rather than irreversible accumulation of damage. The discovery that somatic cells retain a latent capacity to reset their epigenetic and functional identity fundamentally changed how we think about cellular plasticity, identity, and time.

/* */